NCT03549754 iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
| NCT ID | NCT03549754 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AstraZeneca |
| Condition | Type 2 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 35,000 participants |
| Start Date | 2018-02-17 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 35,000 participants in total. It began in 2018-02-17 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Eligibility Criteria
Inclusion Criteria: 1. Being 18 years or older 2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease 3. Providing written informed consent to participate in the registry Exclusion Criteria: 1. Having a life-threatening co-morbidity with life expectancy below 1 year 2. Participating in an interventional trial requiring informed consent
Contact & Investigator
Hardik Vasnawala, MD
STUDY DIRECTOR
AstraZeneca
Frequently Asked Questions
Who can join the NCT03549754 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03549754 currently recruiting?
Yes, NCT03549754 is actively recruiting participants. Contact the research team at information.center@astrazeneca.com for enrollment information.
Where is the NCT03549754 trial being conducted?
This trial is being conducted at Fortaleza, Brazil, Colatina, Brazil, Salvador, Brazil, Brasília, Brazil and 11 additional locations.
Who is sponsoring the NCT03549754 clinical trial?
NCT03549754 is sponsored by AstraZeneca. The principal investigator is Hardik Vasnawala, MD at AstraZeneca. The trial plans to enroll 35,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.